Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
a16z Capital Management, L.L.C. (CIK 1540358) reported $1.29B across 13 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ($373.6M, 28.95%), FIG ($338.5M, 26.23%), META ($121.6M, 9.42%), RVMD ($89.6M, 6.94%), NAUT ($68.5M, 5.31%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | NAVAN INC | $373.6M | 28.95% | 28.2M | Added | |
| 2 | FIG | FIGMA INC | $338.5M | 26.23% | 16.0M | Trimmed |
| 3 | META | META PLATFORMS INC | $121.6M | 9.42% | 212,531 | Hold |
| 4 | RVMD | REVOLUTION MEDICINES INC | $89.6M | 6.94% | 921,099 | Hold |
| 5 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $68.5M | 5.31% | 17.7M | Hold |
| 6 | SQ | BLOCK INC | $61.2M | 4.74% | 1.0M | Hold |
| 7 | BIOA | BIOAGE LABS INC | $56.5M | 4.38% | 3.2M | Hold |
| 8 | MAZE | MAZE THERAPEUTICS INC | $50.8M | 3.94% | 1.7M | Hold |
| 9 | ERAS | ERASCA INC | $46.3M | 3.59% | 2.9M | Hold |
| 10 | GLTO | DAMORA THERAPEUTICS INC | $32.0M | 2.48% | 1.2M | New |
| 11 | OMDA | OMADA HEALTH INC | $29.0M | 2.25% | 2.3M | Trimmed |
| 12 | CAMP | CAMP4 THERAPEUTICS CORP | $9.4M | 0.73% | 2.1M | Hold |
| 13 | AKTIS ONCOLOGY INC | $7.4M | 0.58% | 415,000 | New | |
| 14 | BITGO HOLDINGS INC | $5.5M | 0.42% | 666,356 | New | |
| 15 | DNA | GINKGO BIOWORKS HOLDINGS INC | $665,522 | 0.05% | 108,568 | Hold |
| 16 | HTBK | HERITAGE COMM CORP | $0 | 0.00% | 0 | Exited |
| 17 | CASK | IP STRATEGY HOLDINGS INC | $21,843 | 0.00% | 82,740 | New |
Source: SEC Form 13F filings · as of 2026-03-31